z-logo
open-access-imgOpen Access
Is the decrease of CD31 and CD34 a mechanism by which sera from patients with antiphospholipid syndrome alter vascular remodeling in placenta?
Author(s) -
Velasquez Berrio Manuela,
Ángela M. Álvarez,
Bueno Julio,
Cadavid Angela
Publication year - 2015
Publication title -
frontiers in immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.646
H-Index - 124
ISSN - 1664-3224
DOI - 10.3389/conf.fimmu.2015.05.00102
Subject(s) - cd31 , placentation , medicine , trophoblast , antiphospholipid syndrome , matrigel , endothelial stem cell , immunology , placenta , in vitro , andrology , angiogenesis , microbiology and biotechnology , biology , antibody , fetus , pregnancy , biochemistry , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom